AGTX
Price
$0.03
Change
+$0.01 (+50.00%)
Updated
Jul 15 closing price
Capitalization
1.18M
SMMT
Price
$26.35
Change
+$0.15 (+0.57%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
19.46B
16 days until earnings call
Interact to see
Advertisement

AGTX vs SMMT

Header iconAGTX vs SMMT Comparison
Open Charts AGTX vs SMMTBanner chart's image
Agentix
Price$0.03
Change+$0.01 (+50.00%)
Volume$1.3K
Capitalization1.18M
Summit Therapeutics
Price$26.35
Change+$0.15 (+0.57%)
Volume$31.77K
Capitalization19.46B
AGTX vs SMMT Comparison Chart in %
Loading...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGTX vs. SMMT commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTX is a Hold and SMMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (AGTX: $0.03 vs. SMMT: $26.20)
Brand notoriety: AGTX and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGTX: 3% vs. SMMT: 70%
Market capitalization -- AGTX: $1.18M vs. SMMT: $19.46B
AGTX [@Biotechnology] is valued at $1.18M. SMMT’s [@Biotechnology] market capitalization is $19.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGTX’s FA Score shows that 1 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • AGTX’s FA Score: 1 green, 4 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than AGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGTX’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 6 bullish TA indicator(s).

  • AGTX’s TA Score: 4 bullish, 2 bearish.
  • SMMT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both AGTX and SMMT are a good buy in the short-term.

Price Growth

AGTX (@Biotechnology) experienced а +25.96% price change this week, while SMMT (@Biotechnology) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.21%. For the same industry, the average monthly price growth was +15.57%, and the average quarterly price growth was +33.92%.

Reported Earning Dates

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($19.5B) has a higher market cap than AGTX($1.18M). SMMT YTD gains are higher at: 46.820 vs. AGTX (-83.406). AGTX has higher annual earnings (EBITDA): -352.07K vs. SMMT (-235.08M). SMMT has more cash in the bank: 361M vs. AGTX (8.27K). AGTX has less debt than SMMT: AGTX (198K) vs SMMT (6.45M). AGTX (0) and SMMT (0) have equivalent revenues.
AGTXSMMTAGTX / SMMT
Capitalization1.18M19.5B0%
EBITDA-352.07K-235.08M0%
Gain YTD-83.40646.820-178%
P/E RatioN/A26.41-
Revenue00-
Total Cash8.27K361M0%
Total Debt198K6.45M3%
FUNDAMENTALS RATINGS
AGTX vs SMMT: Fundamental Ratings
AGTX
SMMT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10036
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6537
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (3) in the null industry is significantly better than the same rating for SMMT (95) in the Biotechnology industry. This means that AGTX’s stock grew significantly faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for AGTX (100) in the null industry. This means that SMMT’s stock grew somewhat faster than AGTX’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as AGTX (100) in the null industry. This means that SMMT’s stock grew similarly to AGTX’s over the last 12 months.

SMMT's Price Growth Rating (37) in the Biotechnology industry is in the same range as AGTX (65) in the null industry. This means that SMMT’s stock grew similarly to AGTX’s over the last 12 months.

SMMT's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for AGTX (100) in the null industry. This means that SMMT’s stock grew significantly faster than AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGTXSMMT
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
54%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
METCB13.950.84
+6.41%
Ramaco Resources
CCEP96.840.71
+0.74%
Coca-Cola Europacific Partners plc
CVI28.60-0.33
-1.14%
CVR Energy
AIOT4.42-0.11
-2.43%
PowerFleet Inc.
VYNE1.16-0.04
-3.33%
VYNE Therapeutics

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and SMMT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and SMMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
N/A
SMMT - AGTX
31%
Poorly correlated
-5.18%
RLAY - AGTX
30%
Poorly correlated
-4.11%
VRDN - AGTX
25%
Poorly correlated
-3.11%
AAVXF - AGTX
15%
Poorly correlated
N/A
ABCZF - AGTX
11%
Poorly correlated
N/A
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-5.18%
BCDA - SMMT
69%
Closely correlated
-2.19%
TIL - SMMT
53%
Loosely correlated
-5.78%
BNTX - SMMT
53%
Loosely correlated
-0.92%
RLAY - SMMT
46%
Loosely correlated
-4.11%
FHTX - SMMT
42%
Loosely correlated
+0.49%
More